Skip to Main Content

Paper Details

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.
Oncologist
0
2023
Author NameAffiliation
Martijn P LolkemaErasmus MC Cancer Institute
  • 1 - 1

Datasets

Release 1.2